The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of efficacy and safety of IMC002, a VHH-based anti-CLDN18.2 CAR-T therapy, for gastroesophageal cancers.
 
Chao Li
No Relationships to Disclose
 
Tianhang Luo
No Relationships to Disclose
 
Weijia Fang
No Relationships to Disclose
 
Hongfeng Gou
No Relationships to Disclose
 
Jiayi Li
No Relationships to Disclose
 
Jianwei Yang
No Relationships to Disclose
 
Ziwen Fan
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Yueying Peng
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Shuangshuang Zhang
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Zhuoan Cheng
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Ruidong Hao
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Zhenggang Jiang
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Minmin Sun
Employment - Suzhou Immunofoco Biotechnology Co., Ltd.
 
Jianming Xu
No Relationships to Disclose